Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

NCT04203056 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Withdraw of financial support by industry collaborator

Conditions

Schizophrenia
Schizoaffective Disorder, Depressive Type
Schizophreniform Disorder

Interventions

DRUG: Aripiprazole Lauroxil
DRUG: ARI-ORAL
DRUG: AL-NCD

Sponsor

University of California, Los Angeles

Collaborators

[object Object]